News 2023-06-23
Yuriy Abramov, Ph.D., to Present Groundbreaking Insights on Computational Studies of Pharmaceutical Crystals at the 6th David Grand Symposium
Join J-STAR Research, Inc. Executive Director of computational chemistry and data science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational ctudies on the crystallization development and characterization of pharmaceutical crystals, and engage in meaningful discussions with fellow experts in the field. Looking forward to connecting, learning, and making new connections at this prestigious event.
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
